Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Medera Announces Publication of Study Utilizing Machine Learning to Enhance Next-Generation Drug Screening with Human mini-Heart Technology 2024-10-31 20:00
I-Mab to Release Q3 2024 Financial Results on November 14, 2024 2024-10-31 19:00
Cancer trial: retraining immune cells offers new hope for patients in personalized medicine breakthrough 2024-10-31 18:00
ZYMFENTRA® (infliximab-dyyb) coverage continues to increase through partnership with top 3 Pharmacy Benefit Managers (PBMs) 2024-10-31 14:31
Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) Third NDA Accepted by NMPA, locally advanced or metastatic EGFR-mutant NSCLC 2024-10-31 12:02
MGI's DNBSEQ-T20 x2 Selected As A Special Mention In TIME Best Inventions 2024 2024-10-31 10:51
Abionic's CAPSULE PSP Receives FDA Approval for Early Detection of Sepsis; Fapon Introduces Exclusive PSP Solution in China via Licensing Collaboration 2024-10-31 10:26
Akeso Announces First Patient Enrollment in Phase 3 Trial of Ivonescimab Combined with Ligufalimab (CD47) for First-Line Treatment of Head and Neck Squamous Cell Carcinoma (HNSCC), Compared to Pembrolizumab 2024-10-31 08:46
Unleashing the Power of Red Light Therapy: Bestqool's Insights 2024-10-30 21:00
Neurophet partners with Beijing LADO Technology… Intends to establish Joint Venture in China 2024-10-30 21:00
I-Mab to Present Givastomig Phase 1 Optimal Dose Estimation Data at SITC 2024 2024-10-30 19:00
World Stroke Congress | TASTE-2 significantly reduces stroke disability 2024-10-30 15:36
Ban Ki-moon Calls for Global Unity in Pursuit of Sustainable Development at 2024 ESG Global Leaders Conference 2024-10-30 14:26
Pulsenmore Expands Partnership with Clalit Health Services to Deliver 25,000 Home Ultrasound Devices for Remote Prenatal Care 2024-10-30 14:00
Fosun Pharma Announces 2024Q3 Financial Results 2024-10-30 10:41
WuXi AppTec Named Global CRDMO Company of the Year by Frost & Sullivan for the Eighth Consecutive Year 2024-10-30 08:00
Celltrion presents post hoc analysis of LIBERTY studies of ZYMFENTRA®  (infliximab-dyyb) at the American College of Gastroenterology 2024 Annual Scientific Meeting 2024-10-30 03:25
I Peace announces new iPSC lines to reduce immune rejection risk for U.S. population 2024-10-30 02:55
LILYSILK Continues Partnership with National Breast Cancer Foundation for Breast Cancer Awareness Month 2024-10-29 22:00
DeepQure Presents Clinical Results of Laparoscopic RDN at TCT 2024, Demonstrating Cutting-edge Technology and Innovation 2024-10-29 21:00
1 11 12 13 14 15 807